Sign in

CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980373793
Phone
973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Option exercise Director acquired 15,879 shares (option exercise)
  2. 4 Option exercise President and COO acquired 31,760 shares (option exercise)
  3. 4 Option exercise Chief Medical Officer acquired 16,233 shares (option exercise)
  4. 4 Option exercise Director acquired 21,950 shares (option exercise)
  5. 4 Option exercise Chief Executive Officer acquired 90,832 shares (option exercise)
  6. 4 Option exercise Chief Financial Officer acquired 32,625 shares (option exercise)
  7. 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.96 ($19,294)
  8. 4 Open-market buy Chief Financial Officer bought 31,363 shares at an average $0.89 ($27,975)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Financial Officer acquired 350,000 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Chief Medical Officer acquired 61,000 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award President and COO acquired 81,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Executive Officer acquired 96,000 shares (grant or award)

Page 2 of 20 · 395 filings